Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 12:51 PM ET

Date/Time Source News Release
05/28/2025 08:00 AM EDT GlobeNewswire Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
05/08/2025 08:00 AM EDT GlobeNewswire Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update
05/06/2025 08:00 AM EDT GlobeNewswire Compass Therapeutics to Participate in Upcoming May Investor Events
04/28/2025 08:00 AM EDT GlobeNewswire Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
04/21/2025 08:00 AM EDT GlobeNewswire Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
04/02/2025 04:05 PM EDT GlobeNewswire Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
04/01/2025 07:00 AM EDT GlobeNewswire Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
03/31/2025 04:05 PM EDT GlobeNewswire Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer
02/27/2025 08:00 AM EST GlobeNewswire Compass Therapeutics Reports 2024 Financial Results and Provides Corporate Update
01/29/2025 08:00 AM EST GlobeNewswire Compass Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Page
  • 1
  • 2

Additional News

As of June 3, 2025 • 12:51 PM ET

Date/Time Source News Release
05/12/2025 09:51 PM EDT SeekingAlpha Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Compass Therapeutics Inc.
05/11/2025 06:48 PM EDT KlickAnalytics CMPX - Historical Price Movements Surrounding Earnings
05/11/2025 06:43 PM EDT KlickAnalytics CMPX - Historical Earnings Price Analysis
05/08/2025 12:19 PM EDT SeekingAlpha Compass Therapeutics GAAP EPS of -$0.12
04/01/2025 10:22 AM EDT SeekingAlpha Compass Therapeutics posts clinical trial win for biliary tract cancer therapy
04/01/2025 09:08 AM EDT SeekingAlpha Compass Therapeutics rises on trial win for biliary tract cancer therapy
02/28/2025 04:30 AM EST US Earnings Reports Expected earnings - Compass Therapeutics Inc.
02/28/2025 03:26 AM EST SeekingAlpha Compass Therapeutics GAAP EPS of -$0.11 misses by $0.01
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.